Non-invasive, Real-time Anesthetic Drug-monitoring System
- Conditions
- Anesthesia
- Interventions
- Device: CorrecDose Infrared Monitor
- Registration Number
- NCT02776020
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
The aim of this study is to determine efficacy of the "CorrecDose" device to continuously and non-invasively follow the changes in propofol concentrations in the participants' blood.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Women who have signed Informed consent form
- Women undergoing Trans vaginal ovum retrieval (TVOR) for invitro fertilization (IVF) and will be sedated with propofol administered intravenos (IV)
Exclusion Criteria
- Women with background diseases
- Women with chronic use of drug and medication
- Women with peripheral blood vessels problems
- Women with high blood pressure
- Women with body mass index (BMI) score over 35 or less than 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Propofol sedated patients CorrecDose Infrared Monitor Women undergoing a short trans vaginal ovum retrieval (TVOR) will be sedated with propofol , and monitored non-invasively for changes in blood propofol concentration levels. Propofol dosages will be adapted according to patients vital signs and their reaction to noxious stimuli exerted during the trans vaginal ovum retrieval (TVOR) procedure, irrespective to the proposed study in which these participants undergo.Those changes of administered propofol dosages will be observed by the anesthetic drug monitor (ADM). Propfol is administered by the anesthesiologist in a routine manner and according to anesthesiologist discretion .
- Primary Outcome Measures
Name Time Method Changes in Propofol Blood Levels Half hour Graphic display on monitor of real-time changes
- Secondary Outcome Measures
Name Time Method